Quality of life in patients with cutaneous leishmaniasis

Authors

  • Behnaz Khoshnood Shiraz University of Medical Sciences, Shiraz, Iran
  • Hamid Goodarzi Shiraz University of Medical Sciences, Shiraz, Iran
  • Maryam Sadat Sadati Shiraz University of Medical Sciences, Shiraz, Iran
Abstract:

Introduction: Cutaneous Leishmaniasis (CL) is characterized by papules, nodules or ulcers that most often leave permanent scars in exposed areas of body. This condition can have a severe effect on the quality of life in these patients. This study aims to examine the quality of life in patients with CL. Methods: This cross-sectional study evaluated 120 patients (52 males and 67 females) between 16 to 80 years of age, with CL at Shiraz Valfajr health center, Shiraz, Iran. The Dermatology Life Quality Index (DLQI) questionnaire was used for measuring the quality of life. Data on demographics and characteristics of the lesions were also collected. Correspondence: Farhad Handjani, MD. Department of Dermatology, Shiraz University of Medical Sciences. Shiraz, Iran Tel:+98 713 2319049 Email: [email protected] Results: The mean DLQI score was 11.7 with SD=7.15. The highest effect was observed in the realm of feelings, such as nervousness and feeling ashamed while the lowest effect was seen in the sexual relationship of patients. There was a significant difference in DLQI scores in patients with a high number of ulcerated lesions, especially if the ulcers or scars were on the face, than in other cases. Based on DLQI scores, lower quality of life was seen in CL patients. However, there was no significant difference in DLQI scores between men and women. In addition, no significant difference in DLQI scores were detected between other independent variables that were evaluated in this study. Conclusion: Cutaneous leishmaniasis significantly affects the quality of life in these patients.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Quality of life in patients with cutaneous leishmaniasis.

BACKGROUND Leishmaniasis is a zoonotic infection caused by a protozoa belonging to the genus Leishmania. Its clinical manifestations range from a self-healing cutaneous leishmaniasis (CL) to lethal visceral leishmaniasis. We aim to examine the quality of life of patients with CL in Kerman, Iran.  METHODS In this cross-sectional study we evaluated 124 patients with CL. The Dermatology Life Qua...

full text

Evaluation of Quality of Life, Anxiety and Depression in Children with Cutaneous Leishmaniasis

Background Cutaneous leishmaniasis (CL) is a common parasitic infectious disease which is distributed worldwide. Despite low morbidity rate, the disorder negatively impacts on psychological well-being and social life of patients. We aimed to evaluate the frequency of psychiatric morbidity including depression and anxiety levels as well as quality of life (QOL) in...

full text

Antimonial treatment failure rate in patients with cutaneous leishmaniasis

Background: Despite advances in diagnosis and treatment, leishmaniasis is now considered a severe public health problem, particularly in developing countries, such as Iran. Leishmaniasis is among the six most important, parasitic diseases of the world affecting 88 countries in almost every continent. The disease is complex with different clinical presentations such as visceral, cutaneous and mu...

full text

Comparison of efficacy of oral Fluconazole with intramuscular Glucantime in patients with acute cutaneous Leishmaniasis

Background: Cutaneous leishmaniasis is an important skin parasitic disease. Ideal treatment is not found yet and seeking for proper drugs continues. Objective: Comparison of the efficacy of fluconazole with systemic glucantime in patients with acute cutaneous leishmaniasis in Ghaem hospital in Mashhad in 2002. Patients and Methods: During one year of study, all patients with cutaneous leishmani...

full text

Unusual Presentations of Cutaneous Leishmaniasis in Two Iranian Patients

Leishmaniasis affects 1.5-2 million new cases in the world annually. Two major complications of cutaneous leishamaniasis include diffuse cutaneous leishamaniasis (DCL ) occurring in the setting of deficient cell mediated immunity, typically with HIV infection, and chronic cutaneous leishamaniasis (CCL ) developing in approximately 4% of L. tropica infections in Iran and Afghanistan which also m...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 20  issue None

pages  332- 336

publication date 2016-12

By following a journal you will be notified via email when a new issue of this journal is published.

Keywords

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023